Telix Pharmaceuticals (TLX) Other Non-Current Liabilities (2025 - 2026)
Telix Pharmaceuticals' Other Non-Current Liabilities came in at $3.22 million for the quarter ended Jun 30, 2026.
Analysis
Telix Pharmaceuticals (TLX) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends
As of Dec 31, 2025, Telix Pharmaceuticals' Other Non-Current Liabilities was $3.52 million, down 93.4% from the prior year.
- Going back by year, Other Non-Current Liabilities was $53.22 million in the year ended Dec 31, 2024 (+109.4%) and $25.42 million in the year ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,213.59 Bn | 1,182.17 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 652.89 Bn | 572.75 Bn | 17.30 Bn |
| 3 | AbbVie | 506.16 Bn | 479.31 Bn | 12.70 Bn |
| 4 | Merck | 347.97 Bn | 302.40 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.84 Bn | 271.42 Bn | - |
| 6 | Astrazeneca | 262.79 Bn | 236.55 Bn | 12.86 Bn |
| 7 | Amgen | 244.26 Bn | 199.66 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 197.57 Bn | 171.68 Bn | 6.22 Bn |
| 9 | Pfizer | 168.03 Bn | 114.97 Bn | 10.94 Bn |
| 10 | Telix Pharmaceuticals | 3.14 Bn | 2.10 Bn | - |
API Access
Telix Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TLX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();